BERKELEY, Calif. (AP) — Dynavax Technologies Corp. (DVAX) on Thursday reported a loss of $27.4 million in its fourth quarter.

On a per-share basis, the Berkeley, California-based company said it had a loss of 45 cents. Losses, adjusted for amortization costs, came to 43 cents per share.

The biopharmaceutical company posted revenue of $21,000 in the period.

For the year, the company reported that its loss narrowed to $95.2 million, or $1.81 per share. Revenue was reported as $327,000.

Dynavax Technologies shares have decreased 6 percent since the beginning of the year. The stock has more than tripled in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on DVAX at

Automated Insights

Recommended for you

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.